These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3088112)

  • 61. A simple three-step purification procedure for interleukin 3 involving absorption to fixed cells.
    Murthy SC; Eaves CJ; Krystal G
    Exp Hematol; 1989 Nov; 17(10):997-1003. PubMed ID: 2806440
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Close location of genes of interleukin 3 and granulocyte-macrophage colony-stimulating factor in the human genome].
    Ovchinnikov IuA; Dolganov GM; Frolova EI
    Dokl Akad Nauk SSSR; 1988; 303(3):750-2. PubMed ID: 3074904
    [No Abstract]   [Full Text] [Related]  

  • 63. Biomolecule-cell interactions and the regulation of myelopoiesis.
    Broxmeyer HE
    Int J Cell Cloning; 1986 Nov; 4(6):378-405. PubMed ID: 2431075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.
    Clark-Lewis I; Kent SB; Schrader JW
    J Biol Chem; 1984 Jun; 259(12):7488-94. PubMed ID: 6429132
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
    Welte K; Platzer E; Lu L; Gabrilove JL; Levi E; Mertelsmann R; Moore MA
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1526-30. PubMed ID: 3871951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils.
    Gasson JC; Weisbart RH; Kaufman SE; Clark SC; Hewick RM; Wong GG; Golde DW
    Science; 1984 Dec; 226(4680):1339-42. PubMed ID: 6390681
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human interleukin-3-like activity, basophil and eosinophil growth promoting activities and colony stimulating factor derived from several cell lines.
    Tanno Y; Stadler B; Denburg JA
    Int Arch Allergy Appl Immunol; 1987; 83(1):1-5. PubMed ID: 3494685
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Macrophage-activating factor].
    Taniyama T
    Nihon Rinsho; 1989 Mar; 47(3):534-9. PubMed ID: 2499706
    [No Abstract]   [Full Text] [Related]  

  • 69. Characterization of human interleukin-3 receptors on a multi-factor-dependent cell line.
    Kuwaki T; Kitamura T; Tojo A; Matsuki S; Tamai Y; Miyazono K; Takaku F
    Biochem Biophys Res Commun; 1989 May; 161(1):16-22. PubMed ID: 2658997
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amino-terminal amino acid sequence of murine colony-stimulating factor 1.
    Ben-Avram CM; Shively JE; Shadduck RK; Waheed A; Rajavashisth T; Lusis AJ
    Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4486-9. PubMed ID: 3925458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biologic properties of molecularly cloned and expressed murine interleukin-3.
    Hapel AJ; Fung MC; Johnson RM; Young IG; Johnson G; Metcalf D
    Blood; 1985 Jun; 65(6):1453-9. PubMed ID: 3922456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.
    Van Snick J; Vink A; Cayphas S; Uyttenhove C
    J Exp Med; 1987 Mar; 165(3):641-9. PubMed ID: 3493321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
    Van Snick J; Cayphas S; Vink A; Uyttenhove C; Coulie PG; Rubira MR; Simpson RJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9679-83. PubMed ID: 2948184
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lymphokine purification by reversed-phase high-performance liquid chromatography.
    Urdal DL; Mochizuki D; Conlon PJ; March CJ; Remerowski ML; Eisenman J; Ramthun C; Gillis S
    J Chromatogr; 1984 Jul; 296():171-9. PubMed ID: 6332819
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Large scale purification and further characterization of a rat liver cell conditioned medium multiplication stimulating activity.
    Dulak NC; Shing YW
    J Cell Physiol; 1977 Jan; 90(1):127-37. PubMed ID: 833209
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity.
    Westbrook CA; Gasson JC; Gerber SE; Selsted ME; Golde DW
    J Biol Chem; 1984 Aug; 259(16):9992-6. PubMed ID: 6332112
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hematopoietic growth factor receptors.
    Krystal G; Alai M; Cutler RL; Dickeson H; Mui AL; Wognum AW
    Hematol Pathol; 1991; 5(4):141-62. PubMed ID: 1794965
    [No Abstract]   [Full Text] [Related]  

  • 79. Eosinophils and fibroblasts: the medium in the mesenchyme.
    Weller PF
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):267-8. PubMed ID: 2696515
    [No Abstract]   [Full Text] [Related]  

  • 80. Murine megakaryocyte colony stimulating factor: its relationship to interleukin 3.
    Williams N; Sparrow R; Gill K; Yasmeen D; McNiece I
    Leuk Res; 1985; 9(12):1487-96. PubMed ID: 3935881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.